assay
≥97% (HPLC)
UniProt accession no.
storage temp.
−20°C
SMILES string
CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc5c[nH]c6ccccc56)NC(=O)CN)[C@@H](C)O)[C@H](C)O)C(=O)NCC(=O)N7CCC[C@H]7C(=O)N[C@@H](Cc8c[nH]cn8)C(=O)N[C@@H](C)CO
Gene Information
human ... GAL(51083)
Biochem/physiol Actions
A potent galanin antagonist at sub-micromolar concentrations.
法规信息
新产品
此项目有
N Yanaihara et al.
Regulatory peptides, 46(1-2), 93-101 (1993-07-02)
23 galanin-related peptides were synthesized by solid phase technology or conventional solution method. The purity of the products was carefully assessed by routine analytical criteria. Using these synthetic peptides, we have investigated the effects of galanins and structurally modified galanin
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持